Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer.

Br J Cancer · 2025 · PMC12322152 · PMID 40481178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In contrast, overexpression of c-JUN showed no effect or a slight trend to higher cell proliferation and a significant decrease in apoptosis in all BRAF V600E CRC cell lines tested (Fig. 5d ).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.